Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
原披露日期：2026-10-29；精度：分钟。
来源原始时间字段：2026-10-29T16:05:45-04:00
本站首次发现：2026-10-29T20:15:25.939Z。
首次资格通过：2026-10-29T20:45:56.165Z；首次公开：2026-10-29T20:45:56.165Z；公开模式：natural_new；自然时槽：2026-10-29T20:45:23.513Z。
来源：SEC（SEC EDGAR 8-K）。事件标题沿用来源原题，分类依据是标题明确披露的事件；计划、申请、签署和完成状态以原题及原文为准，未据此推断后续结果。
查看原始披露 ↗原文限定：Statements contained in this release that are not historical facts are “forward-looking” statements as contemplated by the Private Securities Litigation Reform Act of 1995. These forward-looking statements – including statements regarding Resmed’s projections of future revenue or earnings, expenses, results of operations, new product development, new product launches, new markets for its products, the integration of acquisitions and success of strategic initiatives, including divestitures, our supply chain, domestic and international regulatory developments, litigation, tax outlook, and the expected impact of macroeconomic conditions of our business – are subject to risks and uncertainties, which could cause actual results to materially differ from those projected or implied in the forward-looking statements. Additional risks and uncertainties are discussed in Resmed’s periodic reports on file with the U.S. Securities & Exchange Commission. Resmed does not undertake to update its forward-looking statements.
原文限定：In addition to financial information prepared in accordance with GAAP, we use certain non-GAAP financial measures, such as non-GAAP core constant currency basis, non-GAAP gross profit, non-GAAP gross margin, non-GAAP income from operations, non-GAAP operating margin, non-GAAP net income, and non-GAAP diluted earnings per share, in evaluating the performance of our business. We believe that these non-GAAP financial measures, when reviewed in conjunction with GAAP financial measures, can provide investors better insight when evaluating our performance from core operations and can provide more consistent financial reporting across periods. For these reasons, we use non-GAAP information internally in planning, forecasting, and evaluating the results of operations in the current period and in comparing it to past periods. These non-GAAP financial measures should be considered in addition to, and not superior to or as a substitute for, GAAP financial measures. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. Like all non-GAAP measures, non-GAAP earnings are subject to inherent limitations because they do not include all the expenses that must be included under GAAP. Non-GAAP financial measures as presented herein may not be comparable to similarly titled measures used by other companies.
本站核验来源归属、证券身份及披露时间，不保证公司陈述或投资价值。